CTRI/2009/091/000706已完成1 期
A randomized, open label, multi-dose, two treatment, two-way crossover, steady state, bioequivalence study comparing Amneal Pharmaceuticals Felbamate 600 mg tablets to the Reference Listed Drug (RLD), Felbatol® (felbamate) 600 mg tablets Manufactured by MEDA Pharmaceuticals (formerly Medpointe) in adult male and non-pregnant female epilepsy patients under fasting condition
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Ba/be
入排标准
入选标准
- •1.Male and female patients, 18 years of age or older, diagnosed with refractory epilepsy, who do not respond adequately to alternative treatment.
- •2.Patients should be on a stable dose of Felbamate (1800 to 4800 mg/day given in divided doses three or four times per day) for at least two weeks prior to randomization
排除标准
- •Patients with concurrent psychiatric diagnosis, hematology counts below LLN, history of aplastic anemia or bone marrow suppression, serum transaminases >2x ULN or history or evidence of hepatic dysfunction.
研究者
相似试验
已完成
1 期
A clinical trial to evaluate the blood levels of Felbamate after administration of Amneal Pharmaceuticals felbamate suspension (test) compared to the Reference Drug Felbatol® suspension (felbamate) in epilepsy patientsCTRI/2009/091/000708Amneal Pharmaceuticals28
已完成
不适用
A Study of Methotrexate Tablets 2.5 mg in Adult Patients with Inflammatory Disorder of many joints and/or Patches of Abnormal SkiCTRI/2018/11/016245Intas Pharmaceuticals Limited42
已完成
不适用
To compare bioavailibilityof Capecitabine 500 mg tablets(manufactured by Reliance Life Sciences Pvt.Ltd., India) with Xeloda® (Capecitabine 500 mgtablets distributed by Genentech USA, Inc.) inadult cancer patients under fed condition.CTRI/2017/09/009930Reliance Life sciences Pvt Ltd84
已完成
不适用
A Bioequivalence Study of Capecitabine 500 mg with Xeloda® 500 mg in Adult Cancer Patients Under Fed Condition.CTRI/2021/09/036815SP Accure Labs Pvt Ltd33
已完成
Unknown
An single dose, two-treatment, two-way crossover study of study product containing glutathione, in healthy, adult, human subjects under fasting conditions.CTRI/2023/08/056674YourZooki holdings Ltd24